MingCeler

About:

MingCeler is a Bio-Island Laboratory incubation enterprise focused on developing TurboMice™ tetraploid compensation technology.

Website: https://www.mingceler.com

Top Investors: ECC Capital, Guangzhou Finance Holdings, Shenzhen Zhirong, Hunan Enyi

Description:

MingCeler is a Bio-Island Laboratory incubation enterprise focused on developing TurboMice™ tetraploid compensation technology. It provides high-end, fast, and excellent model biological technology services and resources for pharmaceutical companies, vaccine companies, universities, research institutes, hospitals, and other life and health-related research teams.

Total Funding Amount:

10M CNY

Headquarters Location:

Guangzhou, Guangdong, China

Founded Date:

2022-01-01

Contact Email:

sales(AT)mingceler.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2024-10-23

IPO Status:

Private

Industries:

© 2025 bioDAO.ai